tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
LYEL
Lyell Immunopharma
RESEARCH TOOLSreports

Lyell Immunopharma (LYEL) Balance Sheet

153 Followers

Lyell Immunopharma Balance Sheet

Lyell Immunopharma's total assets for Q4 2025 were $340.05M, a decrease of -16.65% from the previous quarter. LYEL total liabilities were $91.85M for the fiscal quarter, a 16.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 340.05M$ 490.86M$ 750.03M$ 937.56M$ 1.13B
Total Liabilities
$ 91.85M$ 108.03M$ 95.08M$ 104.31M$ 197.62M
Total Equity Gross Minority
$ 248.20M$ 382.82M$ 654.95M$ 833.25M$ 929.79M
Other Metrics
Currency in USD

Lyell Immunopharma Debt to Assets